Therefore, the murine TXA2/OIR model demonstrated catch-up growth and increased serum EPO aligning with a previous rat IUGR/OIR model.12 Also, hematocrit, which clinically affects ROP,24 was no different between groups at the p12 time point. The gene discussed is EPO; the disease is fetal growth restriction.